Biological
huCART-meso cells
huCART-meso cells is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 33.3%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
2(50%)
Phase Distribution
Ph phase_1
4
100%
Phase Distribution
4
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
4(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Active, not recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
33.3%
Most Advanced
Phase 1
Trials by Phase
Phase 14 (100.0%)
Trials by Status
terminated250%
active_not_recruiting125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
terminatedphase_1
CAR T Cell Immunotherapy for Pancreatic Cancer
NCT03323944
terminatedphase_1
CAR T Cells in Mesothelin-Expressing Breast Cancer
NCT05623488
active_not_recruitingphase_1
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
NCT05057715
completedphase_1
CAR T Cells in Mesothelin Expressing Cancers
NCT03054298
Clinical Trials (4)
Showing 4 of 4 trials
NCT03323944Phase 1
CAR T Cell Immunotherapy for Pancreatic Cancer
NCT05623488Phase 1
CAR T Cells in Mesothelin-Expressing Breast Cancer
NCT05057715Phase 1
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
NCT03054298Phase 1
CAR T Cells in Mesothelin Expressing Cancers
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4